Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127046901 | 12704690 | 1 | I | 2015 | 20160725 | 20160831 | 20160831 | PER | US-ASTRAZENECA-2016SE81332 | ASTRAZENECA | 62.00 | YR | F | Y | 104.30000 | KG | 20160831 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127046901 | 12704690 | 1 | PS | BYETTA | EXENATIDE | 1 | Subcutaneous | 18265 | UG | AZ160022 | 0 | 5 | UG | SUSPENSION FOR INJECTION IN PRE-FILLED PEN | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127046901 | 12704690 | 1 | Diabetes mellitus inadequate control |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127046901 | 12704690 | Decreased appetite | |
| 127046901 | 12704690 | Product quality issue | |
| 127046901 | 12704690 | Underdose | |
| 127046901 | 12704690 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127046901 | 12704690 | 1 | 2010 | 0 |